Last reviewed · How we verify
NCT07341425
Focused Acceptance and Commitment Therapy (FACT) for Stress, Anxiety, and Depression
NA trial testing Focused Acceptance and Commitment Therapy in Focused Acceptance and Commitment Therapy (FACT) in 60 participants. Not yet recruiting.
30 June 2027
Quick facts
| Lead sponsor | University of Aarhus |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 5 January 2026 |
| Primary completion | 30 June 2027 |
| Estimated completion | 30 June 2028 |
Drugs / interventions tested
- Focused Acceptance and Commitment Therapy
Conditions studied
- Focused Acceptance and Commitment Therapy (FACT) — all drugs for Focused Acceptance and Commitment Therapy (FACT) →
- Wailist — all drugs for Wailist →
Sponsor
University of Aarhus
Who can join
18 and older, any sex, with Focused Acceptance and Commitment Therapy (FACT) or Wailist. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is an interventional study examining the feasibility and acceptability of Focused Acceptance and Commitment Therapy (FACT) as a short-term intervention. Sixty participants will be randomized to either an intervention group (FACT; receiving a maximum of 250 min treatment) or a waitlist control group (receiving treatment after four months). Inclusion criteria are elevated symptoms of anxiety (GAD-7 ≥ 9), depression (PHQ-9 ≥ 10), and/or stress (PSS ≥ 14). Participants will complete self-report questionnaires at baseline, post-treatment, and at 1- and 3-month follow-ups. Additionally, brief session questionnaires will be completed before and after each session. Recruitment will take place through general practi-tioners in the Aarhus area.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07341425
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Focused Acceptance and Commitment Therapy
Trials testing the same drug.
- NCT06262646 — Video-conferencing FACT for Young Children With Special Needs · NA · completed
- NCT05803252 — Videoconferencing-based Focused Acceptance and Commitment Therapy for Parents of SHCN Children · NA · completed
- NCT05584059 — Pai.ACT Programme for Parents of Children With Special Healthcare Needs - Phase I · NA · recruiting
Other University of Aarhus trials
Trials by the same sponsor.
- NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
- NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
- NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
- NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07341425 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
- Last refreshed: 14 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07341425.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing